Effects of some motion sickness suppressants on tracking performance during angular accelerations.

Schroeder, David J.; Collins, William E.; Elam, Gary W.; Civil Aeromedical Institute

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Effects of some motion sickness suppressants on tracking performance during angular accelerations.

1982-10-01
By Schroeder, David J. ; Collins, William E. ; Elam, Gary W.

[PDF-1.03 MB]

English

Details You May Also Like

Details:

Creators:

Schroeder, David J. ; Collins, William E. ; Elam, Gary W.

Schroeder, David J. ; Collins, William E. ; Elam, Gary W. Less -
Corporate Creators:

Civil Aeromedical Institute
Corporate Contributors:

United States. Office of Aviation Medicine
Subject/TRT Terms:

[+]

Acceleration (Physiology) Air Pilots Angular Acceleration Drug Effects Drugs--Physiological Effect Experiments Eye Fixations Eye Location Eye Movements Human Subject Testing Motion Sickness Nystagmus Performance Performance--Testing Static And Dynamic Tests Vision--Testing Vision Tests
Publication/ Report Number:

FAA-AM-82-19 ; DOT/FAA/AM-82/19

FAA-AM-82-19 ; DOT/FAA/AM-82/19 Less -
Resource Type:

Tech Report
Geographical Coverage:

United States
Corporate Publisher:

Civil Aerospace Medical Institute
Abstract:

The two studies reported here examined the influence of three established antimotion sickness drugs on tracking performance in static (stationary) and dynamic (angular acceleration) conditions and on visual fixation ability during motion.

In Study I, 40 young men were randomly assigned in equal numbers to either a control (lactose placebo), dimenhydrinate (50 mg), promethazine hydrochloride (25 mg), or mixture (25 mg promethazine plus 10 mg d-amphetamine) group.

Study II used 30 new subjects equally divided into control, dimenhydrinate (100 mg), and promethazine (50 mg) groups. Following practice, tests were conducted prior to 1, 2, and 4 hours after drug ingestion. The depressant drugs had little effect on static tracking, but impaired dynamic tracking performance and reduced ability to maintain visual fixation on a localizer/glide slope instrument due to increased ocular nystagmus. The mixture of promethazine and d-amphetamine produced none of these deleterious effects.
Format:

PDF
Collection(s):

FAA Civil Aerospace Medical Institute US Transportation Collection
Main Document Checksum:

[+]

urn:sha256:27521fa04aa760b4a7e828c522d8f1c32295b9e82dfb782ad08811207e06a56e
Download URL:

https://rosap.ntl.bts.gov/view/dot/21223/dot_21223_DS1.pdf
File Type:

No Additional Files

More +

Effects of some motion sickness suppressants on tracking performance during angular accelerations.

Details:

Supporting Files

You May Also Like